These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2012353)

  • 21. Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function.
    Jindal K; West M; Bear R; Goldstein M
    Am J Kidney Dis; 1992 Jan; 19(1):61-7. PubMed ID: 1739084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
    Matsumoto Y; Shimada Y; Nojima Y; Moriki T
    Ren Fail; 2013 Aug; 35(7):936-41. PubMed ID: 23815417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.
    Yang S; Xie L; Xue W; Yin A; Lu W
    Nephrology (Carlton); 2013 Sep; 18(9):615-22. PubMed ID: 23889815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognosis and treatment of membranous glomerulonephritis-a 5-year prospective study].
    Covic A; Căruntu ID; Marian D; Volovăţ C; Ghiciuc C; Costin C; Florea L; Cotuţiu C; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):63-74. PubMed ID: 12089993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective treatment administration of cyclophosphamide in membranous nephropathy.
    Dede F; Ayili D; Sahiner S
    J Nephrol; 2008; 21(4):560-5. PubMed ID: 18651546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy.
    Li S; Wang L; Zhang M; Zhou W; Fang W; Wang Q; Qi C; Mou S; Shao X; Ni Z
    Nephron; 2017; 135(2):87-96. PubMed ID: 27974710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic membranous nephropathy in the elderly.
    Passerini P; Como G; Viganò E; Melis P; Pozzi C; Altieri P; Ponticelli C
    Nephrol Dial Transplant; 1993; 8(12):1321-5. PubMed ID: 8159299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
    Cattran DC; Delmore T; Roscoe J; Cole E; Cardella C; Charron R; Ritchie S
    N Engl J Med; 1989 Jan; 320(4):210-5. PubMed ID: 2643046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS-associated membranous nephropathy with advanced renal failure: response to prednisone.
    Mattana J; Siegal FP; Schwarzwald E; Molho L; Sankaran RT; Gooneratne R; Ahuja TS; Singhal PC
    Am J Kidney Dis; 1997 Jul; 30(1):116-9. PubMed ID: 9214410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and treatment outcome of idiopathic membranous nephropathy in Chinese patients.
    Tang S; Chan TM; Cheng IK; Lai KN
    QJM; 1999 Jul; 92(7):401-6. PubMed ID: 10627890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.
    Torres A; Domínguez-Gil B; Carreño A; Hernández E; Morales E; Segura J; González E; Praga M
    Kidney Int; 2002 Jan; 61(1):219-27. PubMed ID: 11786104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression can arrest progressive renal failure due to idiopathic membranous glomerulonephritis.
    Williams PS; Bone JM
    Nephrol Dial Transplant; 1989; 4(3):181-6. PubMed ID: 2498775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis.
    Lu W; Gong S; Li J; Luo H; Wang Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19804. PubMed ID: 32311997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic membranous glomerulonephritis in the elderly.
    Bizzarri D; Imperiali P; Duranti E; Sasdelli M
    Contrib Nephrol; 1993; 105():65-70. PubMed ID: 8252873
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide.
    Donadio JV; Holley KE; Ferguson RH; Ilstrup DM
    Mayo Clin Proc; 1976 Aug; 51(8):484-94. PubMed ID: 950801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases.
    Tse WY; Howie AJ; Adu D; Savage CO; Richards NT; Wheeler DC; Michael J
    Nephrol Dial Transplant; 1997 May; 12(5):1017-27. PubMed ID: 9175062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.
    van de Logt AE; Beerenhout CH; Brink HS; van de Kerkhof JJ; Wetzels JF; Hofstra JM
    PLoS One; 2015; 10(11):e0142033. PubMed ID: 26562836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
    Hofstra JM; Wetzels JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3534-8. PubMed ID: 18559961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.